Beacon Harbor Wealth Advisors, Inc. Amphastar Pharmaceuticals, Inc. Transaction History

Beacon Harbor Wealth Advisors, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 06, 2024	BUY	$44.49 - $62.93 $2,002 - $2,831	45 Added 0.04%	103,140 $6.38 Million
Q3 2023 Nov 13, 2023	SELL	$45.51 - $65.0 $86,924 - $124,150	-1,910 Reduced 1.82%	103,095 $4.74 Million
Q2 2023 Aug 11, 2023	BUY	$35.77 - $58.38 $3.76 Million - $6.13 Million	105,005 New	105,005 $6.04 Million

279

36.5M

74.3K

22.3K

Ticker AMPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,015,200
Market Cap $1.79B
Description
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...

Get notified when there are updates to the investment portfolio of Beacon Harbor Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Beacon Harbor Wealth Advisors, Inc. with notifications on news.